jak2 | 20771
JAK2 p.V617F mutation diagnostic
Keywords:
CML
Chronic myeloid leukemia
Essential thrombocythemia
Leukocytosis
MPN
Myeloproliferation
Myleoproliferative Neoplasm
Polycythemia vera
Polyglobulia
Splenomegaly
essential thrombocytosis
osteomyelofibrosis
polycythemia
Status
| Material |
|
||
|---|---|---|---|
| Hint |
Since in rare cases there may also be indications of hereditary changes, the GUMG (Federal Law on Genetic Testing in Humans) provides for the patient to be informed accordingly (see www.viollier.ch/en/SGMG_consent). |
||
| Min. volume | 4 mL | ||
| Stability |
Stability
1 day / 18-25°C; 4 days / 2-8°C
|
||
| Duration | 3 days | ||
| Frequency | 2 x per week | ||
| Method | digital PCR |
Price/Rate
| Price |
Price
CHF 54.90
|
|---|---|
| Rate |
Rate
54.90 TP
|
| AL Position | 6001.03 |
| Extraktion von menschlichen Nukleinsäure |
Reference values
| Value and unit | Age and unit | Sex |
|---|---|---|
| negative | f+m |
